Literature DB >> 32156462

A multi-sectoral, non-governmental program for control of rheumatic heart disease: SUR I CAAN: A model for developing countries.

Sulafa Ali1, Saad Subahi2.   

Abstract

Rheumatic heart disease (RHD) is a leading cause of cardiovascular mortality in developing countries. Control of RHD requires addressing the disease at its different stages through health system variables that are complex and intersecting. To achieve that, a multi-sectoral program is needed that is best implemented through ministries of health. In this report we present the SUR I CAAN program (Surveillance, Integration, Communication, Awareness, Advocacy and Training) that is implemented in Sudan utilizing nongovernmental resources and nonconventional funding. The program objectives are: 1. To improve primary, secondary and tertiary prevention of RHD, 2. To improve public awareness, 3. To implement strategic research projects, and 4. To improve advocacy through collaboration with regional and international organizations dealing with RHD. We established a hospital-based register and managed to identify high burden areas where sentinel sites for RHD control were established. A package of training and awareness material was utilized to conduct training workshops in these areas. Handheld echocardiography was utilized for studying the prevalence as well as for early detection and treatment of RHD. Although we did not conduct a structured evaluation for this program, we believe that its structure can serve as a model for other resource-limited countries.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Control program; Rheumatic heart disease; Sudan

Mesh:

Year:  2020        PMID: 32156462     DOI: 10.1016/j.ijcard.2020.03.009

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  1 in total

1.  Rheumatic heart disease prevalence in Namibia: a retrospective review of surveillance registers.

Authors:  Panduleni Penipawa Shimanda; Stefan Söderberg; Scholastika Ndatinda Iipinge; Ebba Mwalundouta Neliwa; Fenny Fiindje Shidhika; Fredrik Norström
Journal:  BMC Cardiovasc Disord       Date:  2022-06-14       Impact factor: 2.174

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.